betamethasone-17,21-dipropionate and Streptococcal Infections

betamethasone-17,21-dipropionate has been researched along with Streptococcal Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Desai, A; Janaki, VR; Mittal, RR; Savant, S; Sengupta, S	1

Other Studies

1 other study(ies) available for betamethasone-17,21-dipropionate and Streptococcal Infections

Article	Year
Evaluation of safety and efficacy of supirocin-B (mupirocin 2% + betamethasone dipropionate 0.05%) in infected dermatoses--a post marketing study. Journal of the Indian Medical Association, 2000, Volume: 98, Issue:4 Topics: Betamethasone; Drug Combinations; Humans; India; Mupirocin; Ointments; Product Surveillance, Postmarketing; Pyoderma; Staphylococcal Skin Infections; Streptococcal Infections; Treatment Outcome	2000

Article

Year

Evaluation of safety and efficacy of supirocin-B (mupirocin 2% + betamethasone dipropionate 0.05%) in infected dermatoses--a post marketing study.

Journal of the Indian Medical Association, 2000, Volume: 98, Issue:4

Topics: Betamethasone; Drug Combinations; Humans; India; Mupirocin; Ointments; Product Surveillance, Postmarketing; Pyoderma; Staphylococcal Skin Infections; Streptococcal Infections; Treatment Outcome

2000